Kimberly-Clark Corporation (KMB)

Nov 11, 2026

This article compares Kimberly-Clark (KMB) and Colgate-Palmolive (CL) as dividend stocks, focusing on which would pay more over a decade. KMB currently offers a higher yield (4.6% vs. 2.2%) but has a tighter dividend payout ratio, especially after its recent Kenvue acquisition. CL, while having a lower yield, boasts a more robust cash flow coverage for its dividend. Despite KMB's integration risks, the analysis concludes that its higher initial yield would likely result in greater total dividend payments over 10 years, assuming both companies maintain their historical dividend growth rates.

Nov 11, 2026

This article examines the safety of Cardinal Health's (NYSE:CAH) dividend, which is favored by Jim Cramer and listed among his top dividend stocks. Despite a small recent dividend increase, the company's strong operating cash flow, even after accounting for litigation payments, suggests its dividend is secure. The analysis compares Cardinal Health's dividend sustainability to other consumer and pipeline stocks Cramer has discussed, highlighting cash flow as a key indicator.

Nov 11, 2026

Jim Cramer discussed the day's market movements, noting a Nasdaq rally driven by AI stocks and strong CoreWeave earnings, while the Dow declined. He announced plans for the Investing Club to exit Intel and acquire Advanced Micro Devices due to AMD's superior offerings. Cramer also identified buying opportunities in Kimberly-Clark and Qnity Electronics, and highlighted Johnson & Johnson's oncology business growth.

Nov 10, 2026

Procter & Gamble (PG) is one of the world's largest consumer product manufacturers, generating over $87 billion in annual sales from a portfolio of leading brands. A Morningstar analyst report, published on November 10, 2026, highlights the company's accelerating sales growth as evidence of its strategic course. The report provides a current stock price of $168.32 and details the company's economic moat and stewardship.

Nov 8, 2026

Kimberly-Clark (KMB) has consistently raised its dividend for 54 consecutive years, increasing its quarterly payout from $0.26 in 1999 to $1.28 despite stagnant revenue. However, the company's free cash flow in 2025 barely covered its dividend payments, and a recent $49 billion acquisition of Kenvue, funded partly by debt, introduces potential earnings dilution. Income investors are closely watching for signs of whether the dividend streak can continue amidst these financial pressures and integration challenges.

Nov 6, 2026

Suzano significantly beat third-quarter estimates due to strong pulp market performance and the consolidation of its Arbex joint venture. While pulp operations showed increased earnings, volumes, and margins, the company faced higher cost guidance, weaker performance in paper and packaging, and increased leverage following the Arbex acquisition. The overall sentiment suggests that the positive impact of the pulp upcycle may already be reflected in the stock price, with future performance dependent on sustained pulp prices and debt reduction.

Nov 6, 2026

Suzano reported solid Q3 2026 results, including the successful integration of Arbex, which significantly enhanced its business portfolio. The company maintained stable pro forma leverage at 3.4 times, with a strong focus on reducing net debt and leveraging efficiency gains from Arbex. Despite geopolitical challenges and rising cash costs, Suzano saw robust sales volumes and pricing, especially in the pulp market, and expects a strong Q4 performance while focusing on operational efficiency and deleveraging.

Nov 6, 2026

Suzano (NYSE:SUZ) announced record third-quarter 2026 revenue of R$16.5 billion, a 36% increase year-over-year, driven by the consolidation of its Arbex joint venture. The company also reported a 9% rise in Adjusted EBITDA to R$5.7 billion and net income of R$2.1 billion. This consolidation expanded Suzano's consumer goods operations and international revenue base, with full incorporation of Arbex's earnings expected by Q2 2027.

Nov 5, 2026

Nvidia's forward price-to-earnings multiple has fallen below that of Kimberly-Clark, making the AI chipmaker cheaper than many consumer staples companies. This valuation shift is due to a sharp drop in Nvidia's share price and consistently rising earnings outlook. The market currently values the predictable demand for consumer staples more highly than Nvidia's rapid revenue growth, despite analysts maintaining a "Buy" consensus rating for Nvidia stock.

Nov 5, 2026

Kimberly-Clark Corp. reported better-than-expected third-quarter 2026 results despite facing challenges like rising costs, market uncertainty, and lingering sales damage from unsubstantiated diaper allegations in China. The company reaffirmed its full-year outlook, supported by strong performance in North American tissue and personal care businesses, and completed the acquisition of Kenvue. Management indicated that rebuilding consumer trust in China would take time, and a North American product launch was postponed to 2027.

Nov 5, 2026

Kimberly-Clark reported third-quarter 2026 results where adjusted earnings surpassed analyst estimates due to lower interest costs and a reduced effective tax rate, despite a 6.6% year-over-year decline. However, net sales missed expectations, falling 0.4% to $4.134 billion, primarily impacted by pricing pressures and disruptions in China. The company reaffirmed its 2026 standalone outlook and completed the acquisition of Kenvue to expand its health and wellness portfolio.

Nov 5, 2026

The Kraft Heinz Co. plans to divest its North America coffee business, including brands like Maxwell House and Gevalia, to One Rock Capital Partners for $650 million, while retaining a 30% equity stake. This move is part of Kraft Heinz's broader restructure plan to prioritize key growth areas and pay down debt. The transaction is expected to close in mid-2027 and reflects a strategic pivot in the consumer goods industry, which has seen significant M&A activity and business overhauls.

Nov 5, 2026

Kimberly-Clark completed its acquisition of Kenvue, marking a significant milestone in its transformation strategy, with plans to enhance capabilities in consumer goods and healthcare. The company reported solid Q3 results, noting strong performance in North America, particularly in tissue and personal care, despite some headwinds like cost pressures and a social media crisis in China. Strategic initiatives include a focus on seamless integration with a three-phase plan (Ready, Set, Grow) and leveraging synergies, with a target of $1.9 billion in cost synergies, focusing on overhead, COGS, and sales/marketing efficiencies.

Nov 5, 2026

Kimberly-Clark reported Q3 adjusted earnings of $1.70 per share, exceeding analyst expectations, despite a 0.4% drop in net sales to $4.1 billion. The company faced a significant headwind from a social media disruption in China, which impacted organic sales and operating profit. Kimberly-Clark maintained its 2026 outlook, anticipating continued impact from the China disruptions but expecting growth in adjusted operating profit and earnings per share.

Nov 5, 2026

Kimberly-Clark Corporation published its slide deck for the 2026 Q3 earnings call. This article was created by SA Transcripts, which is responsible for publishing thousands of quarterly earnings calls on Seeking Alpha. The profile aims to share new transcript-related developments with readers.

Nov 4, 2026

Texas Instruments (TXN) has been named Zacks' Bull of the Day due to its strong performance in analog semiconductors, benefiting from industrial automation, automotive electrification, and data center expansion, leading to significant earnings upgrades. Conversely, KimberlyClark (KMB) is the Bear of the Day, facing challenges from stagnant organic growth, disappointing sales trends, and the financial burden of its Kenvue acquisition, resulting in downward earnings revisions. The article also provides an analysis of Palantir Technologies Inc. (PLTR), highlighting its strong revenue growth driven by AI demand but cautioning about its high valuation.

Nov 4, 2026

Kimberly-Clark (KMB) has been designated "Bear of the Day" due to disappointing growth, stagnant sales, and new financial challenges arising from its Kenvue acquisition. The company's stock has underperformed the S&P 500, and analysts have been cutting earnings forecasts, leading to a Zacks Rank #5 (Strong Sell). While the Kenvue acquisition offers potential, the immediate outlook remains uncertain, suggesting investors might find better opportunities elsewhere in the consumer staples sector.

Nov 4, 2026

NICE reported Q3 2026 revenue of $790.7 million, an 8% increase year over year, surpassing analyst estimates. Adjusted earnings per share also exceeded expectations, reaching $2.84. The company announced plans to reduce its global workforce by approximately 5% and raised its full-year adjusted EPS guidance.

Nov 3, 2026

GRIMES & Co WEALTH MANAGEMENT LLC increased its stake in Kimberly-Clark Corporation by 7.1% in the third quarter, acquiring an additional 10,003 shares, bringing their total holdings to 150,072 shares valued at $14.62 million. This comes amidst other institutional investors also acquiring significant positions in the company. Kimberly-Clark recently completed the acquisition of Kenvue, adding brands like Tylenol and aiming for $2.1 billion in synergies, though analysts express concerns about integration risks and potential near-term financial pressures.

Nov 3, 2026

Kimberly-Clark Corporation has announced the completion of its acquisition of Kenvue, creating a global leader in consumer health and wellness. This merger brings together leading portfolios, including 10 billion-dollar brands such as Huggies, Listerine, and Kleenex, aiming to provide extraordinary care for billions worldwide. Mike Hsu, Chairman and CEO of Kimberly-Clark, emphasized the company's commitment to speed and purpose to unlock the full potential of this combination for consumers, customers, and shareholders.

Nov 2, 2026

Mirae Asset Global Investments Co. Ltd. recently acquired 425,116 shares of Kimberly-Clark Corporation (KMB) in the third quarter, valued at approximately $41.4 million. Institutional investors now collectively own 76.29% of KMB, while analyst sentiment remains mixed, with a consensus "Hold" rating and an average price target of $111.56. Kimberly-Clark's latest quarterly results missed expectations, reporting adjusted earnings per share of $1.80 against a $2.01 consensus estimate and revenue of $4.19 billion.

Oct 31, 2026

Kenvue Inc. (KVUE), the largest pure-play consumer health company, recently reported solid earnings with volume outpacing price. The report also indicates that its acquisition by Kimberly-Clark is on track. Kenvue, formerly Johnson & Johnson’s consumer segment, spun off and went public in May 2023, generating over $15 billion in annual revenue.

Oct 31, 2026

Okta (OKTA), an identity management and security company, is set to join the S&P 500 index next week. It will replace Kenvue (KVUE), a consumer healthcare firm, which is being delisted following its proposed $40 billion sale to Kimberly-Clark (KMB).

Oct 31, 2026

Kenvue Inc. (NYSE:KVUE) has received a consensus "Hold" rating from thirteen investment analysts, with an average twelve-month price target of $19.33. The company recently reported a 3.2% year-over-year revenue increase to $3.89 billion for the third quarter, exceeding estimates, while EPS was $0.29. Kenvue also offers an annualized dividend of $0.84 per share, yielding about 4.4%, as it approaches a potential acquisition by Kimberly-Clark.

Oct 30, 2026

Kenvue (NYSE:KVUE) reported a 3.2% increase in net sales for the third quarter of 2026, reaching $4.1 billion, marking its fourth consecutive quarter of growth. Diluted EPS rose 5% to $0.22, with adjusted diluted EPS increasing 4% to $0.29. The company also expanded its operating margin to 18.2% and increased free cash flow as it continues its restructuring ahead of a proposed combination with Kimberly-Clark, leading to no forward-looking financial guidance.

Oct 30, 2026

Kimberly-Clark Corporation (NASDAQ:KMB) has successfully completed a private placement of $4.9 billion in senior unsecured notes across five tranches. The proceeds from this offering, along with existing cash and commercial paper borrowings, are intended to finance the company's proposed acquisition of Kenvue Inc. The acquisition remains subject to customary closing conditions.

Oct 29, 2026

Redmond Asset Management LLC has acquired a new stake of 13,873 shares in Kimberly-Clark Corporation, valued at approximately $1.35 million. This purchase is part of broader institutional investment, with 76.29% of the company's stock now held by institutional investors and hedge funds. Despite recent quarterly earnings missing analyst expectations, Kimberly-Clark continues to pay a quarterly dividend of $1.28 per share and maintains an average "Hold" rating from analysts.

Oct 29, 2026

Bausch + Lomb (B+L) reported a 7% overall Q3 growth to $1.38 billion, driven significantly by a 38% increase in Lumify OTC eye drop sales. This positive performance comes as Thomas Appio takes over as interim CEO following Brent Saunders' exit. The company is also anticipating the approval and launch of a Lumify line extension, Lumify N X T, in the first half of 2027.

Oct 29, 2026

Kimberly-Clark (KMB) is scheduled to release its Q3 2026 earnings before market open on November 5th, with analysts anticipating $1.64 EPS on $4.12 billion in revenue. The company missed expectations in the previous quarter, reporting $1.80 EPS against a $2.01 consensus. Despite a generally cautious "Hold" rating from analysts and a $112.21 price target, Kimberly-Clark offers a $1.28 quarterly dividend, yielding 4.7%.